Amcasertib (Synonyms: BBI503) |
カタログ番号GC19027 |
Amcasertib (BBI503) は、経口活性のある低分子マルチキナーゼ阻害剤です。 Amcasertib は、PC-9/GR 細胞における NANOG および CD133 の発現と細胞生存率に対する阻害活性を示します。潜在的な抗腫瘍活性を有する経口投与可能な癌細胞幹細胞性キナーゼ阻害剤として、現在、多くの癌における第I相臨床試験で研究されています。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1129403-56-0
Sample solution is provided at 25 µL, 10mM.
Amcasertib is an orally administered investigational agent designed to inhibit cancer stem cell pathways, including Nanog, by targeting stemness kinases.
Review for Amcasertib
Average Rating: 5
(Based on Reviews and 36 reference(s) in Google Scholar.)Review for Amcasertib
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *